Positive correlations have been reported between p53 immunoreactivity and the presence of S-p53 Abs in patients with esophageal carcinoma [37], gastric carcinoma [38], colorectal carcinoma [39], and ovarian carcinoma [40]. This evidence concerns the gene TP53 and colorectal carcinoma.